SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
…, E Gimenez, V Latorre, C Frances-Gomez… - Journal of Clinical …, 2020 - Elsevier
Background The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic
events in COVID-19 patients has been suggested. By using several experimental …
events in COVID-19 patients has been suggested. By using several experimental …
[HTML][HTML] Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and …
…, I Torres, V Latorre, C Francés-Gómez… - European Journal of …, 2021 - Springer
Whether antibody levels measured by commercially available enzyme or chemiluminescent
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …
immunoassays targeting the SARS-CoV-2 spike (S) protein can act as a proxy for serum …
[HTML][HTML] The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
…, ML López-Redondo, C Francés-Gómez… - PLoS …, 2022 - journals.plos.org
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2
variant identified in Spain in early summer 2020. This mutation has since reappeared …
variant identified in Spain in early summer 2020. This mutation has since reappeared …
Aptamer‐Capped Nanoporous Anodic Alumina for SARS‐CoV‐2 Spike Protein Detection
…, B Sánchez‐Sendra, C Francés‐Gómez… - Advanced Materials …, 2023 - Wiley Online Library
The COVID‐19 pandemic, which began in 2019, has highlighted the importance of testing
and tracking infected individuals as a means of mitigating the spread of the virus. In this …
and tracking infected individuals as a means of mitigating the spread of the virus. In this …
[HTML][HTML] Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor
…, MA Noriega, Y Margolles, C Francés-Gómez… - Sensors & …, 2022 - pubs.rsc.org
The coronavirus (CoV) disease 2019 (COVID-19) is expected to become endemic in the
coming years, meaning that the worldwide society shall be prepared to routinely manage the …
coming years, meaning that the worldwide society shall be prepared to routinely manage the …
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2
P Ruiz-Rodriguez, C Francés-Gómez, Á Chiner-Oms… - Mbio, 2021 - Am Soc Microbiol
We have detected two mutations in the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) at amino acid positions 1163 and 1167 that appeared …
coronavirus 2 (SARS-CoV-2) at amino acid positions 1163 and 1167 that appeared …
Suitability of two rapid lateral flow immunochromatographic assays for predicting SARS‐CoV‐2 neutralizing activity of sera
…, I Torres, V Latorre, C Francés‐Gómez… - Journal of Medical …, 2021 - Wiley Online Library
Assessment of commercial severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
immunoassays for their capacity to provide reliable information on sera neutralizing activity …
immunoassays for their capacity to provide reliable information on sera neutralizing activity …
Adoptive transfer of ex vivo expanded SARS‐CoV‐2‐specific cytotoxic lymphocytes: A viable strategy for COVID‐19 immunosuppressed patients?
…, J Montoro, C Francés‐Gómez… - Transplant Infectious …, 2021 - Wiley Online Library
Cellular and humoral response to acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infections is on focus of research. We evaluate herein the feasibility of expanding virus‐…
infections is on focus of research. We evaluate herein the feasibility of expanding virus‐…
[HTML][HTML] Preservation of anti-SARS-CoV-2 neutralising antibodies in convalescent plasma after pathogen reduction with methylene blue and visible light
…, E Castro, L Navarro, B Vera, C Francés-Gómez… - Blood …, 2022 - ncbi.nlm.nih.gov
Background COVID-19 convalescent plasma (CCP) is an experimental treatment against
SARS-CoV-2. Although there has so far been no evidence of transmission through transfusion, …
SARS-CoV-2. Although there has so far been no evidence of transmission through transfusion, …
[HTML][HTML] Antigens from the Helminth Fasciola hepatica Exert Antiviral Effects against SARS-CoV-2 In Vitro
J Serrat, C Francés-Gómez, D Becerro-Recio… - International journal of …, 2023 - mdpi.com
SARS-CoV-2, the causal agent of COVID-19, is a new coronavirus that has rapidly spread
worldwide and significantly impacted human health by causing a severe acute respiratory …
worldwide and significantly impacted human health by causing a severe acute respiratory …
